AI/ML-Enabled Drug Discovery – Part 1

Paid

Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying novel drug targets, drug design, virtual screening, lead optimization, and ADME/toxicology assessments.

26-27 September 2023

Healthcare

Neurodegeneration Targets

Paid

Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets conference focuses on therapeutic candidates in clinical or earlier stage development that modulate molecules or cellular processes involved in neurodegenerative diseases, especially Alzheimer’s and Parkinson’s disease. Neurodegenerative diseases have a dearth of therapeutic opti

26-27 September 2023

Healthcare